Suppr超能文献

并展示芪葛汤治疗非酒精性脂肪性肝病的调控机制。

and demonstration of the regulatory mechanism of Qi-Ge decoction in treating NAFLD.

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

Postdoctoral Research Station, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.

出版信息

Ann Med. 2023 Dec;55(1):2200258. doi: 10.1080/07853890.2023.2200258.

Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD), a chronic and progressive liver disease, often causes steatosis and steatohepatitis. Qi-Ge decoction (QGD) shows a good effect against NAFLD in the clinic. But the molecular mechanism for QGD in improving NAFLD is unknown.

PURPOSE

This study explored the molecular mechanism of QGD in NAFLD model rats using comprehensive network pharmacology, molecular docking and verification strategies.

METHODS

Active components and targets of QGD were obtained from public database. The overlapped genes between QGD and NAFLD targets were analyzed by enrichment analysis. Active components and targets were used to predict molecular docking analysis. Finally, seven key targets were screened out and the gene expression were verified in the NAFLD rat's liver tissues after QGD treatment.

RESULTS

Fifty-eight common QGD therapeutic targets were associated with NAFLD. Molecular docking demonstrated that seven targets had strong binding ability for the corresponding active ingredients. GO analysis identified 18 biological process entries, which were mainly related to regulation of lipid storage, lipid localization and peptide transport. KEGG analysis identified multiple signaling pathways, which were mainly associated with tumor necrosis factor signaling and NAFLD. data confirmed that the effect of QGD in the treatment of NAFLD was mainly exerted through improving liver steatosis and inflammatory cell infiltration. Additionally, QGD upregulated the expression of MAPK8 and ESR1 and downregulated the transcriptional expression of IL6, VEGFA, CASP3, EGFR and MYC. These targets may affect lipid metabolism by regulating lipid storage and inflammation.

CONCLUSION

The integration of results obtained and indicated that QGD regulates multiple targets, biological processes and signaling pathways in NAFLD, which may represent a complex molecular mechanism by which QGD improves NAFLD.Key messagesQGD intervention is related to multiple biological processes such as inflammation, oxidation and cell apoptosis in NAFLD.Lipid and atherosclerosis, TNF signaling pathway, IL-17 signaling pathway, non-alcoholic fatty liver disease and AGE-RAGE signaling pathway in diabetic complications are the main pathways for QGD intervention NAFLD.The active components of QGD can form good binding with relevant target proteins through intermolecular forces, exhibiting excellent docking activity.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是一种慢性进行性肝病,常导致脂肪变性和脂肪性肝炎。芪葛汤(QGD)在临床上对 NAFLD 有较好的疗效。但 QGD 改善 NAFLD 的分子机制尚不清楚。

目的

本研究采用综合网络药理学、分子对接和验证策略,探讨 QGD 改善 NAFLD 模型大鼠的分子机制。

方法

从公共数据库中获取 QGD 的活性成分和靶点。通过富集分析,分析 QGD 与 NAFLD 靶点之间的重叠基因。利用活性成分和靶点预测分子对接分析。最后,筛选出 7 个关键靶点,并在 QGD 治疗后验证 NAFLD 大鼠肝组织中的基因表达。

结果

58 个共同的 QGD 治疗靶点与 NAFLD 相关。分子对接表明,7 个靶点与相应的活性成分具有很强的结合能力。GO 分析鉴定出 18 个生物学过程条目,主要与脂质储存、脂质定位和肽转运的调节有关。KEGG 分析鉴定出多个信号通路,主要与肿瘤坏死因子信号和 NAFLD 有关。数据证实,QGD 治疗 NAFLD 的作用主要是通过改善肝脂肪变性和炎症细胞浸润来发挥的。此外,QGD 上调 MAPK8 和 ESR1 的表达,下调 IL6、VEGFA、CASP3、EGFR 和 MYC 的转录表达。这些靶点可能通过调节脂质储存和炎症来影响脂质代谢。

结论

结果的整合表明,QGD 通过调节多个靶点、生物过程和信号通路来调节 NAFLD,这可能代表了 QGD 改善 NAFLD 的复杂分子机制。关键信息QGD 干预与 NAFLD 中的炎症、氧化和细胞凋亡等多个生物学过程有关。脂质和动脉粥样硬化、TNF 信号通路、IL-17 信号通路、非酒精性脂肪性肝病和糖尿病并发症中的 AGE-RAGE 信号通路是 QGD 干预 NAFLD 的主要通路。QGD 的活性成分可以通过分子间力与相关靶蛋白形成良好的结合,表现出良好的对接活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b97/10281479/26d1ed0befaa/IANN_A_2200258_F0001_C.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验